Naltrexone/bupropion
(Redirected from Mysimba)
Naltrexone/Bupropion[edit | edit source]
Naltrexone/bupropion is a combination medication used for weight management in adults. It combines two drugs: naltrexone, an opioid antagonist, and bupropion, an atypical antidepressant. This combination is marketed under the brand name Contrave, among others.
Mechanism of Action[edit | edit source]
Naltrexone and bupropion work together to affect the central nervous system. Naltrexone is primarily used to manage alcohol and opioid dependence by blocking the euphoric effects of these substances. Bupropion, on the other hand, is used to treat depression and aid in smoking cessation. When combined, these drugs influence the hypothalamus and the mesolimbic dopamine circuit, which are involved in regulating appetite and energy balance.
Clinical Use[edit | edit source]
Naltrexone/bupropion is prescribed as part of a comprehensive weight management program that includes a reduced-calorie diet and increased physical activity. It is indicated for use in adults with an initial body mass index (BMI) of 30 kg/m_ or greater (obese) or 27 kg/m_ or greater (overweight) in the presence of at least one weight-related comorbid condition such as hypertension, type 2 diabetes mellitus, or dyslipidemia.
Side Effects[edit | edit source]
Common side effects of naltrexone/bupropion include nausea, constipation, headache, vomiting, dizziness, insomnia, dry mouth, and diarrhea. Serious side effects may include seizures, increased blood pressure, and liver damage. Patients are advised to monitor for any unusual changes in mood or behavior, as bupropion can increase the risk of suicidal thoughts and behaviors.
Contraindications[edit | edit source]
Naltrexone/bupropion is contraindicated in patients with uncontrolled hypertension, seizure disorders, a history of anorexia nervosa or bulimia, and those undergoing abrupt discontinuation of alcohol, benzodiazepines, barbiturates, and antiepileptic drugs. It is also contraindicated in patients who are currently dependent on chronic opioids or opiate agonists, or who are in acute opiate withdrawal.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
